Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emricasan in Liver Cirrhosis
NCT02230670Phase 2Completed
- Sponsor
- Conatus Pharmaceuticals Inc.
- Start
- Aug 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of emricasan in Liver cirrhosis (LC), sponsored by Conatus Pharmaceuticals Inc.. Started Aug 2014; status: completed.
02
Drugs
emricasan
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT02230670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02230670.